Nanosonics Secures FDA Approval to Launch Trophon3, Key Software Upgrade

MT Newswires Live
08/06

Nanosonics (ASX:NAN) has secured US Food and Drug Administration clearance to launch its trophon3 ultrasound disinfection system alongside a new software upgrade for existing trophon2 users, according to a Wednesday Australian bourse filing.

The trophon3 is set to deliver 40% faster disinfection, enhanced digital integration, and industry-leading traceability with new digital imaging and communications in medicine connectivity (DICOM), the filing said.

The launch will drive growth in hospitals and private practices and upgrade 10,000 original devices, while the trophon2 Plus upgrade targets 20,000 existing users, the filing added.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10